Regression of Cardiac Insufficiency After Ambulatory Intravenous Deferoxamine in Thalassemia Major

Chest - United States
doi 10.1378/chest.103.4.1276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparison of Cardiac Dysfunction in Thalassemia Major Patients Using Deferoxamine or Deferiprone as an Iron-Chelating Agent

Paediatrica Indonesiana
2012English

Urinary Iron Excretion Induced by Intravenous Infusion of Deferoxamine in SS-Thalassemia Homozygous Patients

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2002English

Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

American Journal of Hematology
Hematology
2017English

Psy56 - Cost-Utility of New Film-Coated Tablet Formulation of Deferasirox Versus Deferoxamine Among Major B-Thalassemia Patients in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Intravenous Urography in Renal Insufficiency

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1969English

Cardiac Arrest After Treatment With Intravenous Domperidone.

BMJ
1984English

Cardiac Insufficiency.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1991English

Cardiac Abnormalities in Children With Thalassemia Major: Correlation of Echocardiographic Parameters With Serum Ferritin Levels

International Journal of Contemporary Pediatrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy